De Meyer S, Gong Z J, Suwandhi W, van Pelt J, Soumillion A, Yap S H
Department of Liver and Pancreatic Diseases, University Hospital Gasthulsberg, Catholic University Leuven, Belgium.
J Viral Hepat. 1997 May;4(3):145-53. doi: 10.1046/j.1365-2893.1997.00126.x.
Hepatitis B virus (HBV) infection is still a major public health problem worldwide. Although much information about the molecular biology of HBV has been gained in the last decades, little is known about the mechanism of attachment and penetration of the HBV particle into human hepatocytes. The HBV envelope proteins are important for the interaction between the HBV particle and the hepatocyte plasma membrane. Although initially it was suggested that the preS2 domain could act, via polymerized human serum albumin, as an attachment site to human hepatocytes, in recent years other observations showed that the preS1 domain is probably the most important attachment site to human hepatocytes. However, controversial findings on cellular proteins for binding to the preS1 domain has been described, namely the IgA-, the IL6-, the asialoglycoprotein receptor and GAPD. Although the preS1 attachment site may be important, apo H has been shown to bind specifically to small HBsAg. Recently, we have identified human liver Annexin V as a specific small HBsAg-binding protein. In a preliminary report, the direct involvement of human Annexin V in the initial step of HBV infection has been demonstrated. A rat hepatoma cell line, which does not express human Annexin V and which is not infectable by HBV, gained the ability to become infected by HBV after transfection with human Annexin V. This result may facilitate the progress of HBV receptor research and elucidate the molecular mechanism of the initial step of HBV infection.
乙型肝炎病毒(HBV)感染仍是全球主要的公共卫生问题。尽管在过去几十年中已获得了许多关于HBV分子生物学的信息,但对于HBV颗粒附着和穿透人肝细胞的机制仍知之甚少。HBV包膜蛋白对于HBV颗粒与肝细胞质膜之间的相互作用很重要。尽管最初有人提出前S2结构域可通过聚合的人血清白蛋白作为与人肝细胞的附着位点,但近年来其他观察结果表明,前S1结构域可能是与人肝细胞最重要的附着位点。然而,关于与前S1结构域结合的细胞蛋白存在有争议的发现,即IgA、IL6、去唾液酸糖蛋白受体和甘油醛-3-磷酸脱氢酶。尽管前S1附着位点可能很重要,但载脂蛋白H已被证明可特异性结合小分子HBsAg。最近,我们已鉴定出人肝膜联蛋白V是一种特异性小分子HBsAg结合蛋白。在一份初步报告中,已证明人膜联蛋白V直接参与HBV感染的起始步骤。一种不表达人膜联蛋白V且不能被HBV感染的大鼠肝癌细胞系,在用人类膜联蛋白V转染后获得了被HBV感染的能力。这一结果可能会促进HBV受体研究的进展,并阐明HBV感染起始步骤的分子机制。